Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure
Condition(s):Acute Respiratory FailureLast Updated:November 9, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Acute Respiratory FailureLast Updated:November 9, 2021Completed
Condition(s):Pneumonia; Respiratory FailureLast Updated:March 6, 2023Recruiting
Condition(s):Respiratory Failure With Hypoxia; Respiratory Failure Without HypercapniaLast Updated:August 3, 2022Completed
Condition(s):Acute Hypercapnic Respiratory FailureLast Updated:April 11, 2014Unknown status
Condition(s):Hypercapnic Respiratory Failure; Acute Copd ExacerbationLast Updated:August 11, 2022Not yet recruiting
Condition(s):Respiratory FailureLast Updated:June 14, 2012Completed
Condition(s):Pulmonary Disease, Chronic Obstructive; Respiratory InsufficiencyLast Updated:December 19, 2019Completed
Condition(s):Hypercapnic Respiratory Failure; Chronic Obstructive Pulmonary DiseaseLast Updated:October 7, 2014Completed
Condition(s):Pompe DiseaseLast Updated:March 22, 2023Completed
Condition(s):Respiratory InsufficiencyLast Updated:June 22, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.